257 related articles for article (PubMed ID: 32651104)
1. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry.
Azimi A; Lo K; Kim J; Fernandez-Penas P
J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104
[TBL] [Abstract][Full Text] [Related]
2. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
3. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
4. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
[TBL] [Abstract][Full Text] [Related]
5. In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.
Azimi A; Kaufman KL; Ali M; Kossard S; Fernandez-Penas P
Cancer Genomics Proteomics; 2016 11-12; 13(6):453-465. PubMed ID: 27807068
[TBL] [Abstract][Full Text] [Related]
6. Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
Chen W; Rao J; Liu Z; You X; Yuan F; Le F; Tang M; Zhou M; Xie T
J Proteomics; 2021 Sep; 247():104320. PubMed ID: 34237460
[TBL] [Abstract][Full Text] [Related]
7. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors.
Azimi A; Kaufman KL; Kim J; Ali M; Mann GJ; Fernandez-Penas P
J Dermatol Sci; 2020 Jul; 99(1):9-16. PubMed ID: 32312638
[TBL] [Abstract][Full Text] [Related]
8. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
9. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
Br J Dermatol; 2021 Apr; 184(4):709-721. PubMed ID: 32794257
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
11. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
[TBL] [Abstract][Full Text] [Related]
12. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive diagnosis of early cutaneous squamous cell carcinoma.
Azimi A; Jabbour S; Patrick E; Fernandez-Penas P
Exp Dermatol; 2023 Nov; 32(11):1946-1959. PubMed ID: 37688398
[TBL] [Abstract][Full Text] [Related]
16. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR; Harwood CA; Purdie KJ; Gulati A; Matin RN; Romanowska M; Cerio R; Kelsell DP; Leigh IM; Proby CM
Int J Cancer; 2012 Aug; 131(3):E216-26. PubMed ID: 22052591
[TBL] [Abstract][Full Text] [Related]
17. Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness.
Khandelwal AR; Ma X; Egan P; Kaskas NM; Moore-Medlin T; Caldito G; Abreo F; Gu X; Aubrey L; Milligan E; Nathan CA
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):281-8. PubMed ID: 27095050
[TBL] [Abstract][Full Text] [Related]
18. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
20. Active nuclear IKK correlates with metastatic risk in cutaneous squamous cell carcinoma.
Toll A; Margalef P; Masferrer E; Ferrándiz-Pulido C; Gimeno J; Pujol RM; Bigas A; Espinosa L
Arch Dermatol Res; 2015 Oct; 307(8):721-9. PubMed ID: 26094020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
